02/04/2004 AETERNA LABORATORIES

Company

COSCIENS Biopharma Inc.

Filed

February 13, 2004

Accession Number

0000910680-04-000218

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →